As of 2026-04-01, the Relative Valuation of Heat Biologics Inc (HTBX) is (32.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.38 USD, the upside of Heat Biologics Inc based on Relative Valuation is -1447.3%.
The range of the Relative Valuation is (30.11) - (35.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 27.1x | 24.6x |
| Forward P/E multiples | 21.3x - 25.5x | 22.1x |
| Fair Price | (30.11) - (35.14) | (32.07) |
| Upside | -1365.0% - -1576.3% | -1447.3% |
| Date | P/E |